RLMD
Relmada Therapeutics, Inc. · Healthcare
CEO Sergio Traversa sold $144K of Relmada Therapeutics, Inc.
Sold$144,180
$35.43Price
4,070Shares
−5%Stake
What RLMD did after the filing
- The stock from Tue, Jan 26 close, $34.46
- +1.2%
- S&P 500, same days
- +1.5%
Measured over 30 trading days, to the Mar 10 close.
Traded Fri, Jan 22. Filed Tue, Jan 26, 2:29 PM ET, during the session. Returns use the Jan 26 close and the Mar 10 close. Not investment advice.